EUVIMEDEUVIMED entdecken
Open Access

Using Real-World Electronic Health Record Data to Assess Chronic Disease Screening in Children: A Case Study of Non-Alcoholic Fatty Liver Disease

Emily M Kraus iD, Samantha Lange Pierce iD, Renee Porter, Lyudmyla Kompaniyets, Miriam B Vos, Heidi M Blanck, Raymond J King, Alyson B Goodman

Childhood Obesity · 2024

DOI: 10.1089/chi.2022.0208 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Childhood Obesity, 2024. Verfasst von Emily M Kraus und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nutrition, Physical Activity, and Obesity, Centers for Disease Control and Prevention, Atlanta, GA, USA. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Pediatric Obesity. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NINR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Data sources for assessing pediatric chronic diseases and associated screening practices are rare. One example is non-alcoholic fatty liver disease (NAFLD), a common chronic liver disease prevalent among children with overweight and obesity. If undetected, NAFLD can cause liver damage. Guidelines recommend screening for NAFLD using alanine aminotransferase (ALT) tests in children ≥9 years with obesity or those with overweight and cardiometabolic risk factors. This study explores how real-world data from electronic health records (EHRs) can be used to study NAFLD screening and ALT elevation. Research Design: Using IQVIA's Ambulatory Electronic Medical Record database, we studied patients 2-19 years of age with body mass index ≥85th percentile. Using a 3-year observation period (January 1, 2019 to December 31, 2021), ALT results were extracted and assessed for elevation (≥1 ALT result ≥22.1 U/L for females and ≥25.8 U/L for males). Patients with liver disease (including NAFLD) or receiving hepatotoxic medications during 2017-2018 were excluded.

Results

Among 919,203 patients 9-19 years of age, only 13% had ≥1 ALT result, including 14% of patients with obesity and 17% of patients with severe obesity. ALT results were identified for 5% of patients 2-8 years of age. Of patients with ALT results, 34% of patients 2-8 years of age and 38% of patients 9-19 years of age had ALT elevation. Males 9-19 years of age had a higher prevalence of ALT elevation than females (49% vs. 29%).

Conclusions

EHR data offered novel insights into NAFLD screening: despite screening recommendations, ALT results among children with excess weight were infrequent. Among those with ALT results, ALT elevation was common, underscoring the importance of screening for early disease detection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseasePediatric ObesityMaleChildFemaleHumansElectronic Health RecordsOverweightChronic DiseaseBody Mass IndexAlanine Transaminase

Stichwörter der Autor:innen

BMINAFLDchild obesityobesity-related carescreening

Substanzen

Alanine Transaminase

Autor:innen und Institutionen

  • Division of Nutrition, Physical Activity, and Obesity, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Public Health Informatics Institute, Taskforce for Global Health, Atlanta, GA, USA.
  • McKing Consulting Corporation, Atlanta, GA, USA.
  • Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
  • Children's Healthcare of Atlanta, Atlanta, GA, USA.
  • United States Public Health Service, Washington, DC, USA.

ORCID-Profile: Emily M Kraus, Samantha Lange Pierce

Förderung

  • NIDDK NIH HHS
  • NINR NIH HHS

Zitieren

APA

Kraus, E. M., Pierce, S. L., Porter, R., Kompaniyets, L., Vos, M. B., Blanck, H. M., King, R. J., & Goodman, A. B. (2024). Using Real-World Electronic Health Record Data to Assess Chronic Disease Screening in Children: A Case Study of Non-Alcoholic Fatty Liver Disease. Childhood Obesity. https://doi.org/10.1089/chi.2022.0208

Vancouver

Kraus EM, Pierce SL, Porter R, Kompaniyets L, Vos MB, Blanck HM, et al. Using Real-World Electronic Health Record Data to Assess Chronic Disease Screening in Children: A Case Study of Non-Alcoholic Fatty Liver Disease. Childhood Obesity. 2024. doi:10.1089/chi.2022.0208

BibTeX
@article{Kraus2024,
  author = {Kraus, Emily M and Pierce, Samantha Lange and Porter, Renee and Kompaniyets, Lyudmyla and Vos, Miriam B and Blanck, Heidi M and King, Raymond J and Goodman, Alyson B},
  title = {Using Real-World Electronic Health Record Data to Assess Chronic Disease Screening in Children: A Case Study of Non-Alcoholic Fatty Liver Disease},
  journal = {Childhood Obesity},
  year = {2024},
  doi = {10.1089/chi.2022.0208}
}
Kostenlos starten →